Newsletter
How Cell-free DNA Testing is Revolutionizing Care with Paul Billings, Chief Medical Officer and Senior Vice president of Medical Affairs at Natera

Outcomes Rocket

How Cell-free DNA Testing is Revolutionizing Care with Paul Billings, Chief Medical Officer and Senior Vice president of Medical Affairs at Natera

December 2, 2021

How Cell-free DNA Testing is Revolutionizing Care with Paul Billings, Chief Medical Officer and Senior Vice president of Medical Affairs at Natera

In this episode, we are privileged to feature the amazing Dr. Paul Billings. Paul is the Chief Medical Officer and Senior Vice president of Medical Affairs for Natera. Natera is a global leader in cell free (cfDNA) testing with a focus on women’s health, oncology, and organ health. The company is an expert at the process and measurement of cell free DNA and at providing that in context with genetic information as well.

Paul educates us on cell free (cfDNA) testing. He discusses how his company develops millions of testing opportunities in genetics that has given them incredible expertise in measuring very small amounts of cell free DNA. He shares how Natera has developed a series of products to cast light on things like health of a fetus, recurrence of cancer, and health of an organ transplant. Paul also shares his hypothesis on how a drug post organ transplant is working through constant monitoring of cfDNA. He talks about the three indications Natera is working on, providing clear explanations how they add enormous value to genetics and healthcare. There are so many things to learn from this insightful and exciting conversation with Paul, so please tune in!

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Subscribe to Health Podcast Network

Join Our Newsletter

Proudly supported by:

cover
Creating Healthcare IT with Cliff Illig, Co-founder of Cerner Corporation This episode is hosted by Day Zero Advisory Council Member Donald Trigg, Former President, Cerner Corporation.